Get the Stockscreener App
2.75
7.92%
0.10
Entera Bio Ltd stock is traded at $2.75, with a volume of 109.03K.
It is up +7.92% in the last 24 hours and up +58.89% over the past month.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
See More
Previous Close:
$2.65
Open:
$2.69
24h Volume:
109.03K
Relative Volume:
0.73
Market Cap:
$125.57M
Revenue:
$134.00K
Net Income/Loss:
$-9.93M
P/E Ratio:
-8.0882
EPS:
-0.34
Net Cash Flow:
$-6.72M
1W Performance:
+55.43%
1M Performance:
+58.89%
6M Performance:
+69.23%
1Y Performance:
+53.76%
1-Day Range:
$2.59
$2.95
1-Week Range:
$1.87
$2.95
52-Week Range:
$1.5006
$2.95
Entera Bio Ltd Stock (ENTX) Company Profile
Name
Entera Bio Ltd
Sector
Industry
Phone
972-2-532-7151
Address
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Compare ENTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENTX
Entera Bio Ltd
|
2.75 | 121.01M | 134.00K | -9.93M | -6.72M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.64 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.22 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.01 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
795.45 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-22-21 | Initiated | Aegis Capital | Buy |
Entera Bio Ltd Stock (ENTX) Latest News
How rising interest rates impact Entera Bio Ltd. stockJuly 2025 Short Interest & Expert Curated Trade Setup Alerts - newser.com
How Entera Bio Ltd. stock reacts to inflationary pressuresQuarterly Portfolio Report & Trade Opportunity Analysis - newser.com
Predicting Entera Bio Ltd. trend using moving averagesLong Setup & Real-Time Buy Signal Notifications - newser.com
Is it too late to sell Entera Bio Ltd.July 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
How to build a dashboard for Entera Bio Ltd. stockGap Down & Long-Term Capital Growth Strategies - newser.com
Technical analysis overview for Entera Bio Ltd. stockMarket Risk Analysis & Low Risk Investment Opportunities - newser.com
Tick level data insight on Entera Bio Ltd. volatilityWeekly Stock Report & Community Consensus Stock Picks - newser.com
Can swing trading help recover from Entera Bio Ltd. lossesDividend Hike & AI Forecast for Swing Trade Picks - newser.com
Individual investors among Entera Bio Ltd.'s (NASDAQ:ENTX) largest shareholders, saw gain in holdings value after stock jumped 39% last week - simplywall.st
Individual investors are Entera Bio Ltd.'s (NASDAQ:ENTX) biggest owners and were rewarded after market cap rose by US$34m last week - Yahoo Finance
Can Entera Bio Ltd. (5DT) stock reach $200 price targetRisk Management & Consistent Profit Alerts - newser.com
Entera Bio Ltd. stock trend forecastPortfolio Return Summary & AI Driven Stock Reports - newser.com
Key metrics from Entera Bio Ltd.’s quarterly dataMarket Rally & Long-Term Growth Stock Strategies - newser.com
What risks investors should watch in Entera Bio Ltd. stockTrade Performance Summary & High Win Rate Trade Alerts - newser.com
Multi asset correlation models including Entera Bio Ltd.2025 Technical Patterns & Consistent Profit Trade Alerts - newser.com
Will Entera Bio Ltd. stock go up soonJuly 2025 Review & Reliable Momentum Entry Alerts - newser.com
How analysts revise price targets for Entera Bio Ltd. (5DT) stockQuarterly Trade Review & Breakout Confirmation Trade Signals - newser.com
Weiss Ratings Reaffirms “Sell (D-)” Rating for Entera Bio (NASDAQ:ENTX) - Defense World
Could Oral Osteoporosis Treatment Become the Next GLP-1-Style Blockbuster? - openPR.com
What analysts say about Entera Bio Ltd stockPortfolio Allocation Tips & Market Volatility Strategies - earlytimes.in
How Entera Bio Ltd. stock reacts to bond yieldsWeekly Loss Report & Daily Momentum Trading Reports - newser.com
Critical Analysis: Precigen (NASDAQ:PGEN) and Entera Bio (NASDAQ:ENTX) - Defense World
Is Entera Bio Ltd. stock positioned for long term growth2025 Institutional Moves & Real-Time Stock Movement Alerts - newser.com
How Entera Bio Ltd. (5DT) stock stacks up against competitorsInsider Buying & Breakout Confirmation Trade Signals - newser.com
How to build a custom watchlist for Entera Bio Ltd.2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com
Long term hold vs stop loss in Entera Bio Ltd.2025 Earnings Surprises & Daily Stock Trend Reports - newser.com
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates - ADVFN
What drives Entera Bio Ltd 5DT stock priceInstitutional Holding Changes & Free Skyrocketing Profit Margins - earlytimes.in
Hypoparathyroidism Market To Experience Notable Growth In Forecast Span By 2034, Delveinsight Predicts Bridgebio/Calcil Ytix Therapeutics, Ascendis Pharma, Enterabio, Shire - Menafn.com
Entera Bio (NASDAQ:ENTX) Trading Up 7.1% – What’s Next? - Defense World
Entera Bio Ltd 5DT Stock Analysis and ForecastFederal Reserve Announcements & Set Up Real-Time Alerts – It’s Free - earlytimes.in
Entera Bio (NASDAQ:ENTX) Trading Up 7.1%What's Next? - MarketBeat
Entera Bio Ltd Stock (ENTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):